SCHEMBL7014694

SCHEMBL7014694

Cc1nc2[c]cccc2n1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 5/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.33
TP53 P04637 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPT P10636 2/20 0.33
MAPK1 P28482 2/20 0.33
HPGD P15428 1/20 0.33
TNF P01375 1/20 0.32
ATM Q13315 1/20 0.32
HKDC1 Q2TB90 1/20 0.31
GPR3 P46089 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013280 0.79 CLK4 (0.41) KDM4EALDH1A1CYP1A2CYP2D6SMN1; SMN2
SCHEMBL12505433 0.76 KLK5 (0.35) KDM4EALDH1A1LMNASMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL15093740 0.75 KLK5 (0.34) KDM4EALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL3282756 0.74 MAPT (0.39) KDM4EALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL4006181 0.73 KDM4E (0.42) KDM4EALDH1A1LMNACYP3A4SMN1; SMN2
SCHEMBL694295 0.71 ALDH1A1 (0.47) KDM4EALDH1A1LMNACYP3A4CYP1A2
SCHEMBL5547790 0.70 BRD4 (0.39) KDM4EALDH1A1LMNACYP3A4CYP1A2
SCHEMBL1823973 0.68 GRM5 (0.34) KDM4EALDH1A1LMNASMN1; SMN2TP53
SCHEMBL6019625 0.68 KDM4E (0.37) KDM4EALDH1A1LMNAHSD17B10MAPT
SCHEMBL14173318 0.68 KDM4E (0.41) KDM4EALDH1A1LMNACYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051415-B1 BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS FUJISAWA PHARMACEUTICAL CO (JP) 2003-09-24 EP disclosed
US-6495542-B1 SUCH AS 2-METHOXY-N-(2-METHYL-1H-BENZIMIDAZOL-4-YL)-4-(2,3,4,5-TETRAHYDRO-5-OXO-1H-1-BENZAZEPIN-1-YL)CARBONYL-BENZAM IDE; HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-12-17 US disclosed
US-6268514-B1 TREATING INDUSTRIAL MATERIALS WITH NITROETHANE COMPOUND FOR PROTECTING AGAINST ATTACK AND DESTRUCTION BY MICROORGANISMS BASF AKTIENGESELLSCHAFT (DE) 2001-07-31 US disclosed